Shiraz University of Medical Sciences - Iran
Author Profile
SCOPUS
ORCID
🌟 Early academic pursuits
Nargess Arandiforooshani displayed a passion for science from an early age. she pursued her undergraduate studies in cellular and molecular biology at shiraz university, earning her bsc in 2002. determined to delve deeper into the field of immunology, she completed her msc at shiraz university of medical sciences in 2006. her master's thesis, supervised by prof. abbas ghaderi, focused on the "polymorphisms of icam-1 gene in iranian women with breast cancer," marking her initial foray into research. continuing her academic journey, she obtained her phd in immunology from tehran university of medical sciences in 2013, studying the "frequency and functional analysis of regulatory t cells in patients with common variable immunodeficiency (cvid)" under the mentorship of prof. asghar aghamohammadi and prof. abbas mirshafiey.
🏢 Professional endeavors
since December 2013, Dr. Arandiforooshani has been a pivotal figure at the hematology research center, affiliated with shiraz university of medical sciences. as a principal investigator, she has been at the forefront of immunological research, focusing on blood cancers. her expertise encompasses the immunophenotyping of t and b cell subsets and exploring the regulatory mechanisms in allogeneic stem cell transplantation (allo-hsct). she has also been instrumental in supervising numerous thesis projects and mentoring students across various academic levels, contributing significantly to the academic community.
🔬 Contributions and research focus
Dr. Arandiforooshani’s research emphasizes understanding the immune signatures of hematologic malignancies, with particular interest in regulatory t cells (tregs), bregs, and invariant natural killer t (inkt) cells. Transplnat Immunology her groundbreaking work on the prognostic significance of these cells in leukemia, lymphoma, and myeloma has provided valuable insights into the immune regulation of these conditions. she has also pioneered studies on immune checkpoint receptor expression and its correlation with acute graft-versus-host disease (agvhd) following allo-hsct, shaping therapeutic approaches in hematologic oncology.
🏆 Accolades and recognition
As a recognized leader in immunological research, dr. Arandiforooshani has secured numerous research grants and successfully overseen impactful projects. her ability to write compelling Transplnat Immunology research proposals and publish high-quality papers under her correspondence has earned her widespread respect within the scientific community. her contributions to the field have been acknowledged through invitations to collaborate on significant projects and mentor emerging talents in immunology.
🌍 Impact and influence
Dr. Arandiforooshani’s research has far-reaching implications, particularly in advancing the understanding of blood cancer immunology and stem cell transplantation. her findings have Transplnat Immunology influenced clinical practices, offering hope for better diagnostic and therapeutic strategies. as a mentor and educator, she has inspired a generation of medical and specialty students to pursue excellence in research and patient care.
🌱 Legacy and future contributions
with her unwavering dedication to science, dr. arandiforooshani continues to push the boundaries of immunology research. her work promises to unveil new horizons in understanding and treating hematologic malignancies. her legacy lies in her contributions to science and the lasting impact she has made on her students and the broader medical community. her commitment ensures that her influence will resonate for years to come.
Notable Publications
- Title: Altered frequency of FOXP3+ regulatory T cells is associated with development of inhibitors in patients with severe hemophilia A
Authors: Arandi, N., Zekavat, O.R., Shokrgozar, N., Golmoghaddam, H., Kalani, M.
Journal: International Journal of Laboratory Hematology, 2023, 45(6), pp. 953–960
- Title: Selenium Supplementation Alters the Frequency of Th17 but not Th1/Th2 Lymphocytes in Diffuse Large B Cell Lymphoma Patients
Authors: Dehghani, M., Ramzi, M., Moayed, V., Golmoghaddam, H., Arandi, N.
Journal: Clinical Laboratory, 2023, 69(1), pp. 68–76
- Title: Immune Microenvironment in Hematologic Malignancies
Authors: Arandi, N., Dehghani, M.
Journal: Iranian Journal of Medical Sciences, 2023, 48(1), pp. 1–3
- Title: Atopy manifestations in pediatric patients with acute lymphoblastic leukemia: correlation assessment with interleukin-4 (IL-4) and IgE level
Authors: Zekavat, O.R., Nikpendar, E., Haghpanah, S., Dehghani, S.J., Arandi, N.
Journal: BMC Pediatrics, 2022, 22(1), 149
- Title: The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes
Authors: Shokrgozar, N., Dehghani, M., Golmoghaddam, H., Moayed, V., Arandi, N.
Journal: Asia-Pacific Journal of Clinical Oncology, 2022, 18(5), pp. e388–e397